Ariadne Genomics, Inc., today announced that Gene Network Sciences (GNS) has licensed its PathwayStudio® Central software for molecular network modeling and pathway analysis. GNS will use PathwayStudio Central to better interpret in the context of known biology the drug-specific protein and gene networks discovered by the GNS technology platform.
